Patents by Inventor Michael Van Meter

Michael Van Meter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260139069
    Abstract: The present disclosure provides monospecific antigen-binding proteins that bind human SLC3A2-APIS and bispecific antigen-binding proteins that bind to SLC3A2-APIS and CD3 (SLC3A2-APISxCD3). In certain embodiments, the disclosed bispecific antigen-binding proteins include a first antigen-binding domain that binds SLC3A2-APIS and a second antigen-binding domain that binds CD3. In some embodiments, the disclosed antigen-binding proteins inhibit tumor growth. In some embodiments, the disclosed antigen-binding proteins ameliorate one or more symptoms of a myelodysplastic syndrome.
    Type: Application
    Filed: August 26, 2025
    Publication date: May 21, 2026
    Inventors: Michael Van Meter, Frank Kuhnert
  • Publication number: 20240101672
    Abstract: The present disclosure provides antibody-drug conjugates comprising anti-PTCRA antibodies and methods of using the same. The ADCs of the disclosure are useful for the treatment of T-ALL and other disorders related to elevated expression of PTCRA.
    Type: Application
    Filed: October 6, 2023
    Publication date: March 28, 2024
    Inventors: Frank KUHNERT, Michael VAN METER, Thomas NITTOLI
  • Patent number: 11814428
    Abstract: The present disclosure provides antibody-drug conjugates comprising anti-PTCRA antibodies and methods of using the same. The ADCs of the disclosure are useful for the treatment of T-ALL and other disorders related to elevated expression of PTCRA.
    Type: Grant
    Filed: September 18, 2020
    Date of Patent: November 14, 2023
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Frank Kuhnert, Michael Van Meter, Thomas Nittoli
  • Publication number: 20210087272
    Abstract: The present disclosure provides antibody-drug conjugates comprising anti-PTCRA antibodies and methods of using the same. The ADCs of the disclosure are useful for the treatment of T-ALL and other disorders related to elevated expression of PTCRA.
    Type: Application
    Filed: September 18, 2020
    Publication date: March 25, 2021
    Inventors: Frank KUHNERT, Michael VAN METER, Thomas NITTOLI
  • Publication number: 20030165048
    Abstract: A light-generated input interface is provided using a combination of components that include a projector and a sensor. The projector displays an image corresponding to an input device. The sensor can be used to detect selection of input based on contact by a user-controlled object with displayed regions of the projected input device. An intersection of a projection area and an active sensor area on a surface where the input device is to be displayed is used to set a dimension of an image of the input device.
    Type: Application
    Filed: December 9, 2002
    Publication date: September 4, 2003
    Inventors: Cyrus Bamji, James D. Spare, Abbas Rafii, Michael Van Meter, John Bacus, Helena Roeber, Cheng-Feng Sze, Apurva Desai